Tempus AI, Inc. (NASDAQ: TEM) disclosed that its Chief Financial Officer, James William Rogers, sold 7,079 shares of the company's Class A Common Stock on November 17, 2026. The transaction generated proceeds of $446,087, with the shares changing hands at prices between $62.33 and $64.02. Since the sale, Tempus AI's stock has retreated to $59.61, marking a 16.75% decline over the past week.
The sale was not a discretionary trade by the CFO. Instead, it was a mandatory 'sell to cover' transaction, executed to satisfy statutory tax withholding obligations arising from the vesting of restricted stock units. Tempus AI's equity incentive plans require such sales to cover tax liabilities associated with RSU vesting. Following the transaction, Rogers beneficially owns 98,945 shares of Tempus AI Class A Common Stock.
An analysis of the stock suggests that Tempus AI appears overvalued at current levels. Investors seeking more detailed insights can access a comprehensive Pro Research Report covering TEM and over 1,400 other US equities.
In other recent developments, Tempus AI has amended its agreement with AstraZeneca, establishing a new five-year commitment valued at $200 million. Effective January 1, 2027, the agreement ensures AstraZeneca will pay Tempus AI an annual target of $40 million, with a minimum of $32 million per year throughout the renewal period.
Several analyst firms have also adjusted their outlooks on Tempus AI. H.C. Wainwright raised its price target to $85 while maintaining a Buy rating, based on an increased valuation multiple. BTIG lifted its price target to $100, citing strong quarterly results and improved guidance. Jefferies upgraded Tempus AI from Underperform to Hold, setting a new price target of $70, driven by growth in its Data and Applications segments and strategic collaborations. Needham increased its price target to $89, attributing the move to Tempus AI's impressive third-quarter revenue and adjusted EBITDA that surpassed expectations.
Tempus AI Inc (TEM) closed at $59.61, down $4.01 or 6.30%, on the day. In after-hours trading, the stock was at $58.52, down an additional $1.09 or 1.83%.